BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36201667)

  • 21. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
    Ribbing Wilén H; Saraste D; Blom J
    J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial and Ethnic Disparities in Interval Colorectal Cancer Incidence: A Population-Based Cohort Study.
    Fedewa SA; Flanders WD; Ward KC; Lin CC; Jemal A; Goding Sauer A; Doubeni CA; Goodman M
    Ann Intern Med; 2017 Jun; 166(12):857-866. PubMed ID: 28531909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Incidence and Mortality of Colorectal Cancer After Endoscopic Biopsy With Normal Mucosa: A Swedish-Matched Cohort Study.
    Song M; Emilsson L; Hultcrantz R; Roelstraete B; Ludvigsson JF
    Am J Gastroenterol; 2021 Feb; 116(2):382-390. PubMed ID: 33105194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
    Engel C; Vasen HF; Seppälä T; Aretz S; Bigirwamungu-Bargeman M; de Boer SY; Bucksch K; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Järvinen H; Kloor M; von Knebel Doeberitz M; Koornstra JJ; van Kouwen M; Langers AM; van de Meeberg PC; Morak M; Möslein G; Nagengast FM; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Sanduleanu S; Schackert HK; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vecht J; Verhulst ML; de Vos Tot Nederveen Cappel W; Zachariae S; Mecklin JP; Loeffler M;
    Gastroenterology; 2018 Nov; 155(5):1400-1409.e2. PubMed ID: 30063918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Right sided colorectal cancer increases with age and screening should be tailored to reflect this: a national cancer database study.
    Reif de Paula T; Simon HL; Profeta da Luz MM; Keller DS
    Tech Coloproctol; 2021 Jan; 25(1):81-89. PubMed ID: 32852630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Am J Gastroenterol; 2017 Jul; 112(7):1016-1030. PubMed ID: 28555630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of a First-Degree Relative With Colorectal Cancer and Uptake of Screening Among Persons 40 to 54 Years Old.
    Weigl K; Tikk K; Hoffmeister M; Hampe J; Igel S; Kolligs F; Klug SJ; Mansmann U; Müller O; Nagel JM; Pichler M; Schwab M; Schweigler D; Stephan AM; De Toni EN; Brenner H
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2535-2543.e3. PubMed ID: 31809916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimal benefit of earlier-than-recommended repeat colonoscopy among US Medicare enrollees following a negative colonoscopy.
    Yang YX; French B; Localio AR; Brensinger CM; Lewis JD
    Aliment Pharmacol Ther; 2014 Oct; 40(7):843-53. PubMed ID: 25123489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers.
    Chiu HM; Jen GH; Wang YW; Fann JC; Hsu CY; Jeng YC; Yen AM; Chiu SY; Chen SL; Hsu WF; Lee YC; Wu MS; Wu CY; Jou YY; Chen TH
    Gut; 2021 Dec; 70(12):2321-2329. PubMed ID: 33495268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis.
    Jeon J; Meza R; Hazelton WD; Renehan AG; Luebeck EG
    Cancer Causes Control; 2015 Jun; 26(6):859-70. PubMed ID: 25783458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
    Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
    Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
    Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer in the 45-to-50 age group in the United States: a National Cancer Database (NCDB) analysis.
    Reif de Paula T; Haas EM; Keller DS
    Surg Endosc; 2022 Sep; 36(9):6629-6637. PubMed ID: 34888710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Colorectal Cancer in Patients Younger Than 50 Years of Age the Same Disease as in Older Patients?
    Dharwadkar P; Greenan G; Singal AG; Murphy CC
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):192-194.e3. PubMed ID: 31669054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer.
    Mouchli MA; Ouk L; Scheitel MR; Chaudhry AP; Felmlee-Devine D; Grill DE; Rashtak S; Wang P; Wang J; Chaudhry R; Smyrk TC; Oberg AL; Druliner BR; Boardman LA
    World J Gastroenterol; 2018 Feb; 24(8):905-916. PubMed ID: 29491684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
    Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
    World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interval colorectal cancer: a challenging field in colorectal cancer.
    Dong SH; Huang JQ; Chen JS
    Future Oncol; 2018 Jun; 14(13):1307-1316. PubMed ID: 29741114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low Rate of Cancer Detection by Colonoscopy in Asymptomatic, Average-Risk Subjects with Negative Results From Fecal Immunochemical Tests.
    Longstreth GF; Anderson DS; Zisook DS; Shi JM; Lin JC
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2929-2936.e1. PubMed ID: 32007541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.